Moteur de recherche d’entreprises européennes

Financement de l’UE (236 340 €) : Optimizing Antiambipolarity in OMIECs for Efficient Biohybrid Synapses Hor11/03/2025 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Optimizing Antiambipolarity in OMIECs for Efficient Biohybrid Synapses

Neurological diseases are now the leading contributor to the global health burden, affecting one in three individuals worldwide. In response to this critical issue, the development of innovative organic mixed ionic-electronic conductors (OMIECs) that emulate the ion-regulated electronic conductivity and dynamics of biological ion channels when implemented in organic electrochemical transistors (OECTs) has paved the way for electronic devices capable of replicating neuronal functionality, namely conductance-based organic electrochemical neurons (c-OECNs). Despite the progress towards emulating biological neuron functions, current c-OECNs are limited by their inability to generate biologically plausible spike frequencies and their high power consumption, which hinder their integration with biological systems. In this sense, OASYS plans to overcome this challenge by developing innovative OMIECs with optimized ambipolarity characteristics and fabricating wearable and biorealistic c-OECNs that can be fully integrated with biological systems. This will be realized by using rationally designed bithiophene imide (BTI)-based polymers that operate at low gate voltages, enabling faster OECT devices with reduced power consumption and enhanced spike frequencies. OASYS integrates cutting-edge polymer design, advanced material characterization, and innovative device engineering in an application-oriented approach to tackle critical challenges such as antiambipolar tunability, selective sensing, wearability, and biointegration.


FORSCHUNGSZENTRUM JULICH GmbH ?
Linkopings Universitet 236 340 €

https://cordis.europa.eu/project/id/101208856

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Forschungszentrum Julich GmbH, Jülich, Allemagne.

Creative Commons License Les visualisations de "FORSCHUNGSZENTRUM JULICH GmbH - Financement de l’UE (236 340 €) : Optimizing Antiambipolarity in OMIECs for Efficient Biohybrid Synapses" sont mis à disposition par North Data et peuvent être réutilisées selon les termes de la licence Creative Commons CC-BY.